Search results
Results from the WOW.Com Content Network
General dosage ranges of anabolic steroids Medication Route Dosage range [a] Danazol: Oral: 100–800 mg/day Drostanolone propionate: Injection: 100 mg 3 times/week Ethylestrenol: Oral: 2–8 mg/day Fluoxymesterone: Oral: 2–40 mg/day Mesterolone: Oral: 25–150 mg/day Metandienone: Oral: 2.5–15 mg/day Metenolone acetate: Oral: 10–150 mg ...
At doses 20% higher than those used in GH deficiency, growth accelerates. With several years of treatment the median gain in adult height is about 5-8 cm on this dose. The gains appear to be dose-dependent. [14] It has been used successfully in toddlers with Turner syndrome, [15] as well as in older girls. [1] [2] [3] [16]
Growth hormones in sports refers to the use of growth hormones (GH or HGH) for athletic enhancement, as opposed to growth hormone treatment for medical therapy. Human Growth Hormone is a prescription medication in the US, meaning that its distribution and use without a prescription is illegal. [1]
The main growth hormone produced by recombinant DNA technology has the approved generic name somatropin and the brand name Humatrope [4] and is properly abbreviated rhGH in the scientific literature. Since its introduction in 1992, Humatrope has been a banned sports doping agent [ 5 ] and in this context is referred to as HGH.
3479 16000 Ensembl ENSG00000017427 ENSMUSG00000020053 UniProt P05019 P05017 RefSeq (mRNA) NM_000618 NM_001111283 NM_001111284 NM_001111285 NM_001111274 NM_001111275 NM_001111276 NM_010512 NM_184052 NM_001314010 RefSeq (protein) NP_000609 NP_001104753 NP_001104754 NP_001104755 NP_001104744 NP_001104745 NP_001104746 NP_001300939 NP_034642 Location (UCSC) Chr 12: 102.4 – 102.48 Mb Chr 10: 87.69 ...
CJC-1295 may markedly increase plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in animals and humans. [1] [2] [3] [5] With a single injection, in human subjects, CJC-1295 DAC may increase plasma GH levels by 2- to 10-fold for 6 days or longer and plasma IGF-1 levels by 0.5- to 3-fold for 9 to 11 days. [3]
Lonapegsomatropin, sold under the brand name Skytrofa, is a human growth hormone used for the treatment of growth hormone deficiency. [1] [3] Lonapegsomatropin is a prodrug of somatropin.
Somapacitan should not be used in people with active malignancy, any stage of diabetic eye disease in which high blood sugar levels cause damage to blood vessels in the retina, acute critical illness, or those with acute respiratory failure, because of the increased risk of mortality with use of pharmacologic doses of somapacitan in critically ill individuals without growth hormone deficiency.